NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, reports financial results for the three and nine months ended September 30, 2019 and provides a business update. “Overall demand for Avenova was strong during the quarter with unit sales remaining steady with the prior year despite the significantly reduced size of our salesforce. We are pleased with the sale